{"entity":{"type":"insider","cik":"0001556914","url":"/insider/0001556914","json_url":"/insider/0001556914.json","name":"Marek David C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2022-01-21","last":"2023-01-20","span_basis":"filed_date"},"name_variants":[{"name":"Marek David C","source":"filing","n_filings":5,"first_seen":"2022-01-21","last_seen":"2023-01-20"}],"transactions":[{"id":8324750,"accession":"0001209191-23-004282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004282","line_url":"/filing/0001209191-23-004282#line-1","is_derivative":false,"issuer_cik":"0001556914","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001556914","owner_cik":"0001556914","owner_name":"Marek David C","owner_display_name":"Marek David C","owner_url":"/insider/0001556914","role":"Director, Officer (Principal Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8037.0,"shares_display":"8,037","price_per_share":26.89,"price_display":"26.89","price_state":"stated","total_value":216114.93,"total_display":"216,114.93","total_whole":"216,115","shares_owned_after":417599.0,"shares_owned_after_display":"417,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider"},{"id":6127054,"accession":"0001209191-22-054196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054196","line_url":"/filing/0001209191-22-054196#line-1","is_derivative":false,"issuer_cik":"0001556914","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001556914","owner_cik":"0001556914","owner_name":"Marek David C","owner_display_name":"Marek David C","owner_url":"/insider/0001556914","role":"Director, Officer (Principal Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11156.0,"shares_display":"11,156","price_per_share":25.2,"price_display":"25.20","price_state":"stated","total_value":281131.2,"total_display":"281,131.20","total_whole":"281,131","shares_owned_after":425636.0,"shares_owned_after_display":"425,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider"},{"id":6824822,"accession":"0001209191-22-042688","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042688","line_url":"/filing/0001209191-22-042688#line-1","is_derivative":false,"issuer_cik":"0001556914","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001556914","owner_cik":"0001556914","owner_name":"Marek David C","owner_display_name":"Marek David C","owner_url":"/insider/0001556914","role":"Director, Officer (Principal Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11164.0,"shares_display":"11,164","price_per_share":12.87,"price_display":"12.87","price_state":"stated","total_value":143680.68,"total_display":"143,680.68","total_whole":"143,681","shares_owned_after":436792.0,"shares_owned_after_display":"436,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-20","scope":"insider"},{"id":6273272,"accession":"0001209191-22-025170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025170","line_url":"/filing/0001209191-22-025170#line-1","is_derivative":false,"issuer_cik":"0001556914","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001556914","owner_cik":"0001556914","owner_name":"Marek David C","owner_display_name":"Marek David C","owner_url":"/insider/0001556914","role":"Director, Officer (Principal Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24594.0,"shares_display":"24,594","price_per_share":10.45,"price_display":"10.45","price_state":"stated","total_value":257007.3,"total_display":"257,007.30","total_whole":"257,007","shares_owned_after":447956.0,"shares_owned_after_display":"447,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-21","scope":"insider"},{"id":6651236,"accession":"0001209191-22-004396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004396","line_url":"/filing/0001209191-22-004396#line-1","is_derivative":false,"issuer_cik":"0001556914","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001556914","owner_cik":"0001556914","owner_name":"Marek David C","owner_display_name":"Marek David C","owner_url":"/insider/0001556914","role":"Director, Officer (Principal Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19882.0,"shares_display":"19,882","price_per_share":14.68,"price_display":"14.68","price_state":"stated","total_value":291867.76,"total_display":"291,867.76","total_whole":"291,868","shares_owned_after":337983.0,"shares_owned_after_display":"337,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-19","filed_date":"2022-01-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001679082","name":"Myovant Sciences Ltd.","url":"/issuer/0001679082","role":"Director, Officer (Principal Executive Officer)","n_filings":5,"first_seen":"2022-01-21","last_seen":"2023-01-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001556914","retrieved_at":"2026-08-26T19:31:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}